Scientists at the University of South Australia have come up with an innovative solution to improve the effectiveness of ...

First patient dosed in Phase II OCULE-01 study with roginolisib, an allosteric modulator of PI3Kd The European Medicines Agency (EMA) has granted Orphan Drug Designation for ...

Scientists at the University of South Australia have come up with an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative ...

Bank of New York Mellon Corp lifted its position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 8.9% ...

US Bancorp DE raised its holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 144.7% in the 4th quarter, HoldingsChannel reports. The fund owned 1,424 shares of the company’s stock ...

Scientists at the University of South Australia have come up with an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative ...

Completed strategic review to focus on oncology and liver diseases with the acquisition of global rights to GB3226 (formerly BRM-1420), a dual ...

Two students from North Bergen High School earned top honors in early March at the annual Jersey City Medical Center/RWJBarnabas Health Hudson County STEM Showcase. Christopher Robles received a gold ...

OvationLab pioneers innovative supplement research and development, offering scientifically validated, high-quality products ...

Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 19.78%, which has investors questioning if this is right ...

Bexobrutideg, a first-in-class Bruton’s tyrosine kinase degrader, has been granted orphan drug designation from the FDA in ...